Skip to main content
SHANGHAI OBIO TECHNOLOGY (GROUP) CORP., LTD. logo

SHANGHAI OBIO TECHNOLOGY (GROUP) CORP., LTD. — Investor Relations & Filings

Ticker · 688238 ISIN · CNE1000059N9 Shanghai Stock Exchange Manufacturing
Open in API
Filings indexed 482 across all filing types
Latest filing 2025-04-17 Regulatory Filings
Country CN China
Listing Shanghai Stock Exchange 688238

About SHANGHAI OBIO TECHNOLOGY (GROUP) CORP., LTD.

https://www.obio-tech.com/

SHANGHAI OBIO TECHNOLOGY (GROUP) CORP., LTD. is a specialized Contract Development and Manufacturing Organization (CDMO) focused on the gene and cell therapy (GCT) sector. The company provides end-to-end solutions encompassing vector construction, process development, analytical method development, and large-scale GMP manufacturing. Its service portfolio includes the production of viral vectors such as adeno-associated virus (AAV), lentivirus, adenovirus, and oncolytic viruses, as well as plasmid DNA and cell therapy products. Obio Technology supports clients from early-stage research through clinical trials to commercialization. The company operates advanced facilities designed to meet international regulatory standards, facilitating the development of innovative genetic medicines and advanced therapies for global biopharmaceutical partners.

Recent filings

Filing Released Lang Actions
2024 年度非经营性资金占用及其他关联资金往来情况的专项审计说明
Regulatory Filings
2025-04-17 Chinese
第三届监事会第十三次会议决议公告
Regulatory Filings Classification · 95% confidence The document is a detailed announcement of resolutions passed at the 13th meeting of the 3rd Supervisory Board of Heyuan Biotech (Shanghai) Co., Ltd. It includes approvals of various reports such as the 2024 Annual Report and its summary, the 2024 Supervisory Board Work Report, the 2024 Internal Control Evaluation Report, the 2024 Financial Final Report, and the 2025 Financial Budget Report. It also covers profit distribution plans, fundraising usage reports, audit firm reappointment, expected related party transactions, cash management proposals, and remuneration plans for 2025. The document repeatedly states that these reports and detailed contents are published on the Shanghai Stock Exchange website and that the resolutions will be submitted to the shareholders' meeting for approval. The document itself does not contain the full financial statements or detailed report contents but is a formal announcement of the Supervisory Board's meeting resolutions regarding these reports and plans. The document length is 4082 characters, which is relatively short and consistent with an announcement rather than a full report. Therefore, according to the "Menu vs Meal" rule, this document is an announcement of the Supervisory Board meeting resolutions and related report approvals, not the reports themselves. This fits best under Regulatory Filings (RNS) as a general regulatory announcement of meeting resolutions and report approvals, not a full Annual Report (10-K) or Interim Report (IR).
2025-04-17 Chinese
关于2024年度募集资金存放与实际使用情况的专项报告
Capital/Financing Update Classification · 95% confidence The document is a detailed report on the company's fundraising (募集资金) for the year 2024, including the amount raised, usage, balance, management, and compliance with regulatory requirements. It references regulatory guidelines from the China Securities Regulatory Commission and the Shanghai Stock Exchange, and includes auditor and sponsor institution opinions on the fundraising usage. The document contains substantive financial data on fundraising amounts, usage, balances, and investment projects, as well as detailed tables and explanations. This matches the description of a Capital/Financing Update (CAP), which covers updates on company fundraising, financing activities, or capital structure changes. The document is not a simple announcement or certification but a comprehensive report on fundraising usage and management for the year. Therefore, the appropriate classification is CAP with high confidence.
2025-04-17 Chinese
2024年可持续发展报告
Regulatory Filings
2025-04-17 Chinese
董事会审计委员会2024年度履职情况报告
Audit Report / Information Classification · 95% confidence The document is titled as the "Board of Directors Audit Committee 2024 Annual Performance Report" of a company. It details the activities, meetings, and evaluations conducted by the audit committee during the 2024 fiscal year, including review of financial reports, internal controls, external audit supervision, and related governance matters. The document is a report on the audit committee's duties and performance rather than a standalone audit report or full annual report. It is not a brief announcement or a certification letter but a detailed committee report on audit-related governance and oversight. This fits the category of Audit Report / Information (AR), which includes reports on audit committee activities and applied accounting principles, distinct from full annual reports or financial statements. The document length is 3475 characters, which is sufficient for a detailed committee report but not a full annual report. Therefore, the classification is AR with high confidence. FY 2024
2025-04-17 Chinese
2024年年度报告
Annual Report Classification · 100% confidence The document is titled "和元生物技术（上海）股份有限公司 2024 年年度报告" which translates to "Obio Technology (Shanghai) Corp., Ltd. 2024 Annual Report." It contains detailed financial data for the fiscal year 2024, including revenue, net profit, earnings per share, and management discussion and analysis sections. The document includes an auditor's report with an unqualified opinion, signatures from company officers guaranteeing the accuracy of the report, and comprehensive financial statements. The length of the document (15,000 characters) and the presence of substantive financial data and analysis confirm it is the full annual report rather than an announcement or summary. Therefore, the document fits the definition of an Annual Report (10-K). FY 2024
2025-04-17 Chinese

Browse filings by year

5 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.